Hernandez-Reynoso, Ana G.
Corona-Quintanilla, Dora L.
López-García, Kenia
Horbovetz, Ana A.
Castelán, Francisco
Zimmern, Philippe
Martínez-Gómez, Margarita
Romero-Ortega, Mario I.
Funding for this research was provided by:
Consejo Nacional de Ciencia y Tecnología (625796/472504)
DGAPA-UNAM
Proprama de Apoyo a Proyectos de Ingestigación e Innovación Tecnológica UNAM (PAPIIT IN212916)
National Institutes of Health (1R01DK120307-01)
Article History
Received: 16 December 2020
Accepted: 30 April 2021
First Online: 19 May 2021
Competing interests
: MRO is a shareholder of a company that has commercial interest in neuromodulation of the PFM. All other authors declare no competing interests.